搜尋結果
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 2 日前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
US Agency to Reclassify Marijuana as a Less Dangerous Drug
Bloomberg· 4 日前Have a confidential tip for our reporters? WASHINGTON (AP) — The U.S. Drug Enforcement Administ ...
TD Probe Tied to Laundering Money From Drug Sales, Journal Says
Bloomberg· 2 日前A US law-enforcement probe into Toronto-Dominion Bank’s internal controls is tied to the ...
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
CNBC· 5 日前A federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers ...
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Forbes· 6 日前There's never been a worse time to get sick in Canada. The Canadian government has chosen ...
Provisional Statistics of Retail Sales for March 2024
Bastillepost· 2 日前The Census and Statistics Department (C&SD) released the latest figures on retail sales today ...
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 3 日前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
Wegovy, Mounjaro prices cut as British pharmacies compete for weight-loss patients
Reuters· 3 日前Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain ...
What Reclassifying Marijuana Would Mean for Sellers, Users
Bloomberg· 1 日前Marijuana is now legal in 24 US states for recreational purposes and in 38 states for medical ...
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg· 2 日前Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by ...